Skip to main content
SCLX logo

SCLX · Scilex Holding Co · Metrics

Track SCLX — free
$2.09 +0.04 (+1.95%) At close · Oct 28
Market Cap
$17.41M
Shares
8.49M
Volume · Oct 28 17.03K Avg daily vol (3M) 44.59K

SCLX metrics

57 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$2.09
Market cap
$17.41M

Price action

20 metrics
Price change (1W)
-19.0%
Price change (30D)
-54.3%
Price change (3M)
-69.9%
Price change (6M)
—
Price change (YTD)
—
Price change (1Y)
—
Trailing year
Price change (5Y)
—
52-week high
—
52-week low
—
Change from 52-week high
—
Change from 52-week low
—
Annualized volatility
87.8%
Annualized volatility (3M)
65.4%
Beta
—
RSI (14D)
14.3
Price vs SMA 50
-53.4%
Price vs SMA 200
—
Avg volume (3M)
46,056
Relative volume
2.2
Average dollar volume
$228,995

Company

3 metrics
Sector
Healthcare
Industry
Drug Manufacturers - General
Shares outstanding
8.49M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
0.6×
reciprocal yield 165.4%
P / book
—
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-2,431.0%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
—

Profitability

9 metrics
Gross margin
—
Operating margin
-1,136.4%
Trailing 12 months
Net margin
-1,469.8%
Gross profit (TTM)
$50.91M
Operating profit (TTM)
−$359.19M
Net income (TTM)
−$464.56M
Trailing 12 months
Diluted EPS (TTM)
$-49.73
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$-29.54

Growth

11 metrics
Revenue growth YoY
-22.8%
Year over year
Net income growth YoY
—
Revenue (TTM)
$31.61M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
-40.6%
Year over year · fewer shares
Revenue CAGR (3Y)
-7.3%
Revenue CAGR (5Y)
+5.1%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
—
Return on assets
-183.2%
Debt / equity
—
Current ratio
0.1
EBITDA (TTM)
−$350.88M
Free cash flow (TTM)
—
Quick ratio
0.1
Interest coverage
-22.2
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$566,000
Total assets
$253.56M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$17.09M
Capital expenditures (TTM)
$726,000
R&D (TTM)
$18.61M
SG&A (TTM)
$277.98M
Stock compensation (TTM)
$16.12M
R&D / revenue
58.9%
Stock compensation / revenue
51.0%

Ownership (13F)

9 metrics
13F filers
77
13F filer change QoQ
0
Institutional ownership
9.8%
Conviction holders (share of 13F filers)
0.0%
Crowding (high-turnover and private-fund holders)
1.5%
Private-fund adviser ownership
1.5%
Active holders' share change QoQ
-52.5%
Holder tenure
4.4
Price vs estimated holder cost
-87.2%

Ownership (registered funds)

1 metrics
Index-fund ownership
4.1%

Short interest

3 metrics
Short interest
1.7%
Latest settlement · 2.6 days to cover
Days to cover
2.6d
Short-squeeze score
35 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
Flagged
Key facts CIK 1820190 CUSIP 80880W205 13F (30d) 16 filings 16 filers Visit website Investor relations